MRVI - Maravai LifeSciences Price to Earnings Adjusted for Growth Rate

Maravai LifeSciences (MRVI) maintained stability through its high-margin CleanCap technology. The P/E to growth rate dynamics visualize this stage, while 0.00 captures the magnitude of this parameter. The established ecosystem of components has made the company an indispensable partner for pharma behemoths. Management is currently adapting its post-pandemic strategy by expanding the product portfolio for traditional biotech to preserve the business's investment attractiveness.

Maravai LifeSciences Corp (MRVI): PEG Multiple from 07/04/2022 to 11/15/2026

Metric breakdowns and analytics for Maravai LifeSciences Holdings (MRVI)

- current price and projected stock value:

Price Chart Maravai LifeSciences|MRVI - Consensus Target

- market capitalization statistics:

Market Value Maravai LifeSciences|MRVI - Total Company Value

- shareholders' equity book value data:

Net Assets per Share Maravai LifeSciences|MRVI - Book Capitalization|Market Capitalization to Book Value maravai.com|MRVI - Aggregate Company Assets

- issuer credit burden and liquidity indicators:

Total Debt to Capital Coefficient Maravai LifeSciences|MRVI - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Maravai LifeSciences Holdings, Inc.|MRVI - Company Aggregate Debts|Debts to Book Capitalization Maravai LifeSciences|MRVI - Company Long-Term Debt|Company Short-Term Loans and Borrowings Maravai LifeSciences|Quick Ratio maravai.com

- net income and valuation ratios data:

MRVI - Net Income|Expected Profit Maravai LifeSciences|MRVI - P/E Multiple|Forward P/E Multiple Maravai LifeSciences|MRVI - PEG Multiple|Total Company Value to Operating Income Before Depreciation Ratio Maravai LifeSciences Holdings, Inc.|MRVI - Operating profit before deduction of amortization|Earnings per share for the trailing year Maravai LifeSciences|MRVI - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last twelve months maravai.com|MRVI - Earnings growth in current year|Consensus forecast of earnings per share growth for next year Maravai LifeSciences

- issuer revenue and sales details:

MRVI - Revenue and Sales Volume|Company Expected Revenue Maravai LifeSciences Corp|MRVI - P/S Multiple|Market Cap to Future Revenue Ratio Maravai LifeSciences|MRVI - Sales Growth YoY (Last Twelve Months)

General company analysis:MRVI Maravai

Core merchandise of Maravai LifeSciences Holdings, Inc.

To identify fundamental stability drivers, the P/E to earnings growth ratio is used to determine whether the market value is fair relative to revenue dynamics. By analyzing the PEG filter for undervalued "rockets," an investor identifies assets with growth potential, which for Maravai LifeSciences (MRVI) is confirmed by its role as a key supplier of critical reagents for hundreds of biotech corporations and gene therapy developers.

Competitors of Maravai LifeSciences